The bioactivity of ectopically expressed PU.1 in CD4+ and CD8+ CAR T cells was addressed by monitoring PU.1 target genes before and after 2 days of stimulation of anti-CEA CAR T cells with CEA+ BxPC-3 pancreatic tumor cells. This evidence concerns the gene CEACAM5 and pancreatic neoplasm.